These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28802532)

  • 1. Challenges and Controversies in Hypertrophic Cardiomyopathy: Clinical, Genomic and Basic Science Perspectives.
    Pasipoularides A
    Rev Esp Cardiol (Engl Ed); 2018 Mar; 71(3):132-138. PubMed ID: 28802532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
    Maron BJ; Maron MS; Semsarian C
    J Am Coll Cardiol; 2012 Aug; 60(8):705-15. PubMed ID: 22796258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy.
    Bos JM; Towbin JA; Ackerman MJ
    J Am Coll Cardiol; 2009 Jul; 54(3):201-11. PubMed ID: 19589432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are longitudinal, natural history studies the next step in genotype-phenotype translational genomics in hypertrophic cardiomyopathy?
    Ackerman MJ; Van Driest SL; Bos M
    J Am Coll Cardiol; 2005 Nov; 46(9):1744-6. PubMed ID: 16256879
    [No Abstract]   [Full Text] [Related]  

  • 5. [Controversies and progress in the management of idiopathic hypertrophic cardiomyopathy].
    Alins I; Alegría E; Iglesias I; García Bolao I; Mejía S; Martínez Caro D
    Rev Med Univ Navarra; 1994; 39(2):65-9. PubMed ID: 7724964
    [No Abstract]   [Full Text] [Related]  

  • 6. The 25-year genetic era in hypertrophic cardiomyopathy: revisited.
    Maron BJ; Maron MS
    Circ Cardiovasc Genet; 2014 Aug; 7(4):401-4. PubMed ID: 25140059
    [No Abstract]   [Full Text] [Related]  

  • 7. [Controversies in hypertrophic cardiomyopathy].
    Hardarson T
    Laeknabladid; 2009 Sep; 95(9):555. PubMed ID: 19738289
    [No Abstract]   [Full Text] [Related]  

  • 8. Summary of Presentations and Discussions of Hypertrophic Cardiomyopathy at the 2018 Boston International Summit VI Including Consensus, Controversies, and Unmet Needs.
    Maron BJ; Maron MS
    Am J Cardiol; 2018 Oct; 122(7):1281-1286. PubMed ID: 30173818
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetics of hypertrophic cardiomyopathy: one, two, or more diseases?
    Bos JM; Ommen SR; Ackerman MJ
    Curr Opin Cardiol; 2007 May; 22(3):193-9. PubMed ID: 17413275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current perspectives in hypertrophic cardiomyopathy: diagnosis, clinical management, and prevention of disability and sudden cardiac death.
    von Dohlen TW; Frank MJ
    Clin Cardiol; 1990 Apr; 13(4):247-52. PubMed ID: 2190723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posterolateral hypertrophic cardiomyopathy: a rare, but clinically significant variant of hypertrophic cardiomyopathy.
    Seki A; Perens G; Fishbein MC
    Cardiovasc Pathol; 2014; 23(6):381-2. PubMed ID: 25108499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Williams-Beuren syndrome with brain malformation and hypertrophic cardiomyopathy.
    Okamoto N; Yamagata T; Yada Y; Ichihashi K; Matsumoto N; Momoi MY; Mizuguchi T
    Brain Dev; 2014 Jun; 36(6):523-7. PubMed ID: 23899771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives on the Overall Risks of Living With Hypertrophic Cardiomyopathy.
    Maron BJ; Maron MS; Rowin EJ
    Circulation; 2017 Jun; 135(24):2317-2319. PubMed ID: 28606946
    [No Abstract]   [Full Text] [Related]  

  • 14. Necropsy finding in a patient with apical hypertrophic cardiomyopathy.
    Sumino S; Sugimoto T; Koide T; Murao S
    Jpn Heart J; 1985 Mar; 26(2):297-303. PubMed ID: 2989576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual ST-segment elevation: apical hypertrophic cardiomyopathy shows the ace up its sleeve.
    de Santis F; Pergolini A; Zampi G; Pero G; Pino PG; Minardi G
    Rev Port Cardiol; 2013; 32(7-8):619-22. PubMed ID: 23831044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrophic cardiomyopathy in Donohue syndrome.
    Termote JU; Breur JM; de Vroede MA
    Cardiol Young; 2016 Apr; 26(4):815-8. PubMed ID: 26555333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies in cardiovascular medicine. Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy.
    Maron BJ
    Circulation; 2007 Jul; 116(2):196-206; discussion 206. PubMed ID: 17620519
    [No Abstract]   [Full Text] [Related]  

  • 18. Current perspectives on sudden cardiac death in hypertrophic cardiomyopathy.
    DeRose JJ; Banas JS; Winters SL
    Prog Cardiovasc Dis; 1994; 36(6):475-84. PubMed ID: 8184099
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular mechanisms in cardiomyopathy.
    Dadson K; Hauck L; Billia F
    Clin Sci (Lond); 2017 Jul; 131(13):1375-1392. PubMed ID: 28645928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
    Hudsmith LE; Petersen SE; Francis JM; Robson MD; Watkins H; Neubauer S
    Int J Cardiovasc Imaging; 2006; 22(3-4):493-5. PubMed ID: 16267621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.